C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/454 (2006.01) A61P 25/04 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01) A61P 27/06 (2006.01) C07D 405/06 (2006.01) C07D 409/06 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2407594
Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
L'invention concerne des composés et des méthodes destinés au traitement d'états pathologiques dans lesquels une modification de l'activité du récepteur cholinergique, spécialement le récepteur muscarinique m1, m4 ou m1 et m4, a un effet bénéfique. Selon la méthode, une dose efficace d'un composé est administrée à un patient pour lequel un tel traitement est nécessaire.
Andersson Carl-Magnus A.
Friberg Bo Lennart M.
Skjaerbaek Niels
Spalding Tracy
Uldam Allan K.
Acadia Pharmaceuticals Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Muscarinic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1799585